|
[Related PubMed/MEDLINE]
Total Number of Papers: 16
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2021 |
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases. |
BCBM, BCs, CGP, IHC, PD-L1, TNBC |
| 2 |
2021 |
Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment. |
BBB, LRP1, MMP-1 |
| 3 |
2021 |
RNA Sequence Profiling Reveals Unique Immune and Metabolic Features of Breast Cancer Brain Metastases. |
BCs, GEO, KM, OXPHOS |
| 4 |
2020 |
Autocatalytic Delivery of Brain Tumor-targeting, Size-shrinkable Nanoparticles for Treatment of Breast Cancer Brain Metastases. |
BBB |
| 5 |
2020 |
Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization. |
MEF2C, miRNAs, NGS |
| 6 |
2020 |
Synergistic Chemotherapy for Breast Cancer and Breast Cancer Brain Metastases via Paclitaxel-Loaded Oleanolic Acid Nanoparticles. |
BMs, NPs, OA, PTX |
| 7 |
2018 |
Management of breast cancer brain metastases. |
EGFR-TKIs, NSCLC |
| 8 |
2018 |
Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies. |
FDA, TNBC |
| 9 |
2017 |
JAK2-binding long noncoding RNA promotes breast cancer brain metastasis. |
Lnc-BM, lncRNA |
| 10 |
2016 |
A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases. |
CAR, oHSV |
| 11 |
2016 |
Regression of experimental NIS-expressing breast cancer brain metastases in response to radioiodide/gemcitabine dual therapy. |
GEM, MFP, NIS, PID |
| 12 |
2014 |
Are capecitabine and the active metabolite 5-Fu CNS penetrable to treat breast cancer brain metastasis? |
5-FU, BC, BM, CNS, CSF, PK |
| 13 |
2014 |
PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer. |
BBB, HER2, mTOR, PI3K |
| 14 |
2014 |
Updates on the management of breast cancer brain metastases. |
--- |
| 15 |
2012 |
New insights and emerging therapies for breast cancer brain metastases. |
ER, HER2, PR |
| 16 |
2011 |
Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases. |
HR, OS, PI3K, PTEN, TTDR |
|
A Search Service for Abbreviation / Long Form
